# Arrival of Wegovy in tablet form and tensions around anti-obesity treatments

> In late October 2026, the anti-obesity treatment Wegovy arrives in tablet form in French pharmacies, with details on its price, availability and prescription. In early November, Professor Emmanuel Disse of the Hospices civils de Lyon speaks on the role of drug treatments for obesity compared with bariatric surgery. Four and a half months after reimbursement of Mounjaro and Wegovy began, waiting times for specialist consultations reach up to 18 months and a parallel market is developing. A patient treated with Mounjaro for three years says she has lost 50 kg.

**In brief**: Ongoing story bringing together 8 events nationwide, followed from 28 October 2026 to 3 November 2026. 52 articles from 22 sources (health); last updated on 3 November 2026 at 16:15.

- Status: ongoing
- Category: Health
- Place: Nationwide
- First detected: 28 October 2026 at 14:50
- Updated: 3 November 2026 at 16:15
- Web page: https://acturadar.com/en/stories/231-arrival-of-wegovy-in-tablet-form-and-tensions-around-anti-obesity-treatments

## Reported figures

- 169 euros
- 235 euros

## Coverage angles

All three sides cover the arrival of Wegovy in tablet form, but the left emphasizes industrial competition and reimbursement conditions, the center develops waiting times, the parallel market and patient testimonies, while the right highlights the non-reimbursable nature and practical information (price, side effects).

**Common ground**

- Wegovy in tablet form is available in pharmacies in France from Monday 2 November.
- The oral version is not reimbursed.
- Wegovy had previously been administered by injection in France.

**Differences**

- The left focuses on competition between laboratories (Novo Nordisk, Eli Lilly), an angle little present on the right.
- The center insists on waiting times of up to 18 months and the parallel market, absent from the left and right headlines provided.
- The center and the right detail price and side effects in a practical format, while the left prioritizes the industrial and regulatory angle.

## What is established

_“Confirmed” = reported by at least two independent outlets (outlets of the same group count as one). AI cross-check of the collected headlines and extracts._

**Confirmed by several sources**

- Wegovy tablets are marketed in France from 2 November. (7 independent sources: [BFMTV / RMC](https://www.bfmtv.com/sante/alimentation/video-l-enquete-de-la-matinale-modalites-de-prescription-effets-secondaires-quels-sont-les-risques-du-traitement-anti-obesite-wegovy_VN-202610290139.html), [Paris-Normandie](http://www.paris-normandie.fr/id755775/article/2026-10-29/wegovy-oral-disponible-en-pharmacie-debut-novembre-ce-quil-faut-savoir), [Midi Libre](https://www.midilibre.fr/2026/10/29/le-medicament-antiobesite-wegovy-sous-forme-de-comprime-date-prix-remboursement-tout-savoir-larrivee-du-traitement-en-france-13626369.php), [20 Minutes](https://www.20minutes.fr/sante/4258692-20261029-obesite-faut-savoir-arrivee-version-comprimes-traitement-wegovy?at_medium=display&at_campaign=149), [La Dépêche du Midi](https://www.ladepeche.fr/2026/10/31/le-wegovy-medicament-contre-lobesite-arrive-en-pharmacie-remboursement-effets-secondaires-ce-quil-faut-savoir-sur-le-traitement-vedette-13627553.php), [CNews](https://news.google.com/rss/articles/CBMitAFBVV95cUxOQmpNbGtPUFk0LUEwLUlhSVJ1Rnlfa3lCX1RSbW5DNnZLaENyckQ0WjdPSVAxV3VOajUtOHFKanY4RVRGWkxkX3JuaFM2ay1MTjdrb0pFRHdoTTJlNThDLVhjTlgxLWNkV1A3MmtHU0VZR1lJTTg4MTF0bmM2ZjUxX25ZRkE3dXdBdkVMUm5oMUs4NW9nYXg3SHlRNC1IV2lGNG9wNTRPNndxRWNqZWVwSWpFS0U?oc=5), [Libération](https://www.liberation.fr/societe/sante/medicament-anti-obesite-le-wegovy-version-comprime-arrive-en-france-20261101_ZQWJVASHSRB4DKFDBP5XECSVOQ/), [Les Échos](https://news.google.com/rss/articles/CBMi8wFBVV95cUxQMHVuOHhHa0xjT0pFczU0X2hPRVZKLTRqOUQ3NEItNEpJak84b3BVSnhuYTJNbnNmN19qckRxR096ZzZSRFphellBV1NpejA5bmNJVUhwMVhVZ01wOWJ4dlFEYXBCdDJCbWpwYndwTi1jNzNvMmRudE53VEhqbW85TVRjSjladEN3bTlIbEttMHozRldJZEpwNzA0UGFiYndRcUthb2V0dTZnamFDWGpiM2FNTU1WR2FUdFBMM2RCbmFqdGFJWm02enlKZ1NfM280VjJYRGZONWJCeWt3Ry0zdVJsQUV1OVFGbnAwc1BCVWZaeWs?oc=5), [TF1 Info / LCI](https://www.tf1info.fr/sante/medicament-anti-obesite-ce-qu-il-faut-savoir-sur-le-wegovy-en-comprime-disponible-en-pharmacie-des-lundi-2473228.html))
- Oral Wegovy is sold at a recommended price of 169 euros per month and is not reimbursed. (5 independent sources: [Midi Libre](https://www.midilibre.fr/2026/10/29/le-medicament-antiobesite-wegovy-sous-forme-de-comprime-date-prix-remboursement-tout-savoir-larrivee-du-traitement-en-france-13626369.php), [Le Moniteur des pharmacies](https://news.google.com/rss/articles/CBMi8AFBVV95cUxPVV9SQ2l2N2hLb283aGRWWnUwUm9wcnQ2TVY5MnpoV3NsLVIxdmpsa1cxLWRsWkFaSlBhYm5VOFhvX2pNV0hVc1dtME9aYjcwc2M2eHlTSF9xRlp3VVR2SnFPbVhuLXFKc0xFZ0xjUEdxcUR2ZGI2RzhERlpycGhxWXNyeEM3RXlEaTF0MFd5YVBTUHFQdGdlaDBDbzdaNUxuWV83ejRzMmJFMUFkTUFZZm04MnA2dHNTZzRGUy00SWdabVR5X0QwU1ItRmhGbWxrVy1melJPYUhjRjVOMmVURFNWYzBTWlZnUXBWZ3BPeks?oc=5), [20 Minutes](https://www.20minutes.fr/sante/4258692-20261029-obesite-faut-savoir-arrivee-version-comprimes-traitement-wegovy?at_medium=display&at_campaign=149), [Libération](https://www.liberation.fr/societe/sante/medicament-anti-obesite-le-wegovy-version-comprime-arrive-en-france-20261101_ZQWJVASHSRB4DKFDBP5XECSVOQ/), [Les Échos](https://news.google.com/rss/articles/CBMi8wFBVV95cUxQMHVuOHhHa0xjT0pFczU0X2hPRVZKLTRqOUQ3NEItNEpJak84b3BVSnhuYTJNbnNmN19qckRxR096ZzZSRFphellBV1NpejA5bmNJVUhwMVhVZ01wOWJ4dlFEYXBCdDJCbWpwYndwTi1jNzNvMmRudE53VEhqbW85TVRjSjladEN3bTlIbEttMHozRldJZEpwNzA0UGFiYndRcUthb2V0dTZnamFDWGpiM2FNTU1WR2FUdFBMM2RCbmFqdGFJWm02enlKZ1NfM280VjJYRGZONWJCeWt3Ry0zdVJsQUV1OVFGbnAwc1BCVWZaeWs?oc=5))
- Waiting times in specialist consultations authorized to prescribe anti-obesity drugs reach up to 18 months. (2 independent sources: [Les Échos](https://news.google.com/rss/articles/CBMi8wFBVV95cUxQMHVuOHhHa0xjT0pFczU0X2hPRVZKLTRqOUQ3NEItNEpJak84b3BVSnhuYTJNbnNmN19qckRxR096ZzZSRFphellBV1NpejA5bmNJVUhwMVhVZ01wOWJ4dlFEYXBCdDJCbWpwYndwTi1jNzNvMmRudE53VEhqbW85TVRjSjladEN3bTlIbEttMHozRldJZEpwNzA0UGFiYndRcUthb2V0dTZnamFDWGpiM2FNTU1WR2FUdFBMM2RCbmFqdGFJWm02enlKZ1NfM280VjJYRGZONWJCeWt3Ry0zdVJsQUV1OVFGbnAwc1BCVWZaeWs?oc=5), [Le Progrès](https://www.leprogres.fr/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [Le Bien Public](https://www.bienpublic.com/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [Le Dauphiné libéré](https://www.ledauphine.com/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [L'Est Républicain](https://www.estrepublicain.fr/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut))
- Oral Wegovy contains semaglutide, a GLP-1 receptor agonist. (2 independent sources: [Paris-Normandie](http://www.paris-normandie.fr/id755775/article/2026-10-29/wegovy-oral-disponible-en-pharmacie-debut-novembre-ce-quil-faut-savoir), [TF1 Info / LCI](https://www.tf1info.fr/sante/medicament-anti-obesite-ce-qu-il-faut-savoir-sur-le-wegovy-en-comprime-disponible-en-pharmacie-des-lundi-2473228.html))
- Injectable Wegovy has been available in France since 2024 and reimbursed under conditions since June 2026. (2 independent sources: [Le Progrès](https://www.leprogres.fr/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [TF1 Info / LCI](https://www.tf1info.fr/sante/medicament-anti-obesite-ce-qu-il-faut-savoir-sur-le-wegovy-en-comprime-disponible-en-pharmacie-des-lundi-2473228.html))

**Single source so far**

- The European Commission authorized oral Wegovy on 15 July 2026. (according to [Paris-Normandie](http://www.paris-normandie.fr/id755775/article/2026-10-29/wegovy-oral-disponible-en-pharmacie-debut-novembre-ce-quil-faut-savoir))
- A parallel market for these drugs is thriving, difficult to quantify. (according to [Le Progrès](https://www.leprogres.fr/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [Le Bien Public](https://www.bienpublic.com/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [Le Dauphiné libéré](https://www.ledauphine.com/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut), [L'Est Républicain](https://www.estrepublicain.fr/sante/2026/11/01/jusqu-a-18-mois-de-delai-pour-les-medicaments-anti-obesite-les-consultations-prises-d-assaut))
- Professor Emmanuel Disse said: "The more patients we treat, the more bariatric surgery there will be." (according to [Le Progrès](https://www.leprogres.fr/sante/2026/11/01/plus-on-traitera-de-patients-plus-il-y-aura-de-chirurgie-bariatrique), [Le Bien Public](https://www.bienpublic.com/sante/2026/11/01/lutte-contre-l-obesite-plus-on-traitera-de-patients-plus-il-y-aura-de-chirurgie-bariatrique), [L'Est Républicain](https://www.estrepublicain.fr/sante/2026/11/01/lutte-contre-l-obesite-plus-on-traitera-de-patients-plus-il-y-aura-de-chirurgie-bariatrique))
- Meta Tshiteya, treated with Mounjaro for three years, has lost 50 kg. (according to [L'Est Républicain](https://www.estrepublicain.fr/sante/2026/11/01/traitee-au-mounjaro-elle-a-perdu-50-kg-on-a-une-persistance-retinienne-de-son-corps-d-avant), [Le Dauphiné libéré](https://www.ledauphine.com/sante/2026/11/01/traitee-au-mounjaro-elle-a-perdu-50-kg-on-a-une-persistance-retinienne-de-son-corps-d-avant), [Le Progrès](https://www.leprogres.fr/sante/2026/11/01/traitee-au-mounjaro-elle-a-perdu-50-kg-on-a-une-persistance-retinienne-de-son-corps-d-avant))
- Oral Wegovy is presented as the first oral GLP-1 receptor agonist. (according to [Paris-Normandie](http://www.paris-normandie.fr/id755775/article/2026-10-29/wegovy-oral-disponible-en-pharmacie-debut-novembre-ce-quil-faut-savoir))

**Checked on the web**

_Automatic web search, official sources first; “contradicted” only when an official source is cited._

- Not confirmed at this stage: Wegovy tablets are marketed in France from 2 November. ([ansm.sante.fr](https://ansm.sante.fr/uploads/2026/07/08/20260708-ansm-ra-2025-2.pdf) (official), [www2.assemblee-nationale.fr](https://www2.assemblee-nationale.fr/static/17/questions/jo/jo_anq_202627.pdf) (official), [rtl.fr](https://www.rtl.fr/actu/sante/info-rtl-depuis-leur-remboursement-l-engouement-pour-les-traitements-contre-l-obesite-se-confirme-avec-86-000-boites-prises-en-charge-7900671942), [franceinfo.fr](https://www.franceinfo.fr/sante/medicament/enfin-une-chance-d-egalite-therapeutique-depuis-juin-85-600-boites-de-medicaments-anti-obesite-vendues-en-france_8213240.html), [lagazettefrance.fr](https://www.lagazettefrance.fr/article/le-remboursement-de-medicaments-contre-l-obesite-un-nouvel-espoir-pour-des-patients))
- Not confirmed at this stage: Oral Wegovy is sold at a recommended price of 169 euros per month and is not reimbursed. ([ansm.sante.fr](https://ansm.sante.fr/uploads/2026/07/08/20260708-ansm-ra-2025-2.pdf) (official), [rtl.fr](https://www.rtl.fr/actu/sante/info-rtl-depuis-leur-remboursement-l-engouement-pour-les-traitements-contre-l-obesite-se-confirme-avec-86-000-boites-prises-en-charge-7900671942), [franceinfo.fr](https://www.franceinfo.fr/sante/medicament/enfin-une-chance-d-egalite-therapeutique-depuis-juin-85-600-boites-de-medicaments-anti-obesite-vendues-en-france_8213240.html), [lagazettefrance.fr](https://www.lagazettefrance.fr/article/le-remboursement-de-medicaments-contre-l-obesite-un-nouvel-espoir-pour-des-patients), [prescrire.org](https://www.prescrire.org/divers/514-semaglutide-wegovy-et-tirzepatide-mounjaro-remboursables-sous-conditions))
- Not confirmed at this stage: The European Commission authorized oral Wegovy on 15 July 2026. ([lagazettefrance.fr](https://www.lagazettefrance.fr/article/le-remboursement-de-medicaments-contre-l-obesite-un-nouvel-espoir-pour-des-patients), [prescrire.org](https://www.prescrire.org/divers/514-semaglutide-wegovy-et-tirzepatide-mounjaro-remboursables-sous-conditions), [ameli.fr](https://www.ameli.fr/assure/actualites/obesite-de-nouveaux-medicaments-peuvent-etre-pris-en-charge-dans-des-conditions-encadrees), [qare.fr](https://www.qare.fr/sante/obesite/medicaments-anti-obesite/mounjaro), [20minutes.fr](https://www.20minutes.fr/sante/4245172-20260914-obesite-plus-85-000-boites-wegovy-mounjaro-deja-remboursees-secu))

## Timeline (8 events)

### 28 October 2026 — [Wegovy tablet arrives in French pharmacies](https://acturadar.com/en/events/2888-wegovy-tablet-arrives-in-french-pharmacies.md)

The anti-obesity treatment Wegovy arrives in tablet form in pharmacies, with details on its price, availability date and prescription.

17 sources, 35 articles · Nationwide

### 1 November 2026 — [Obesity drug treatments: Lyon doctor speaks on their place compared with surgery](https://acturadar.com/en/events/6437-obesity-drug-treatments-lyon-doctor-speaks-on-their-place-compared-with-surgery.md)

Professor Emmanuel Disse, from the Hospices civils de Lyon and coordinator of the Force network, discusses the positioning of obesity drug treatments compared with bariatric surgery.

4 sources, 4 articles · Lyon — Rhône

### 1 November 2026 — [Anti-obesity drugs: up to 18 months' wait for consultations](https://acturadar.com/en/events/6557-anti-obesity-drugs-up-to-18-months-wait-for-consultations.md)

Four and a half months after reimbursement began for Mounjaro and Wegovy, waiting times for specialist consultations are exploding and a parallel market is developing.

5 sources, 5 articles · Nationwide

### 1 November 2026 — [Testimony from a patient treated with Mounjaro who lost 50 kg](https://acturadar.com/en/events/6579-testimony-from-a-patient-treated-with-mounjaro-who-lost-50-kg.md)

A patient treated with Mounjaro for three years says she lost 50 kilograms and has published an account of her perception of her body after the transformation.

3 sources, 3 articles · Not located

### 2 November 2026 — [Dijon : les limites du remboursement des traitements anti-obésité](https://acturadar.com/en/events/6772-dijon-les-limites-du-remboursement-des-traitements-anti-obesite.md)

Après l'annonce du remboursement des traitements médicaux de l'obésité, professionnels et patients de Dijon font face à des critères d'IMC stricts et à des démarches complexes pour obtenir une prescription.

1 sources, 1 articles · Dijon — Côte-d'Or

### 3 November 2026 — [Les douanes renforcent les contrôles face au trafic de coupe-faims comme le Wegovy](https://acturadar.com/en/events/7812-les-douanes-renforcent-les-controles-face-au-trafic-de-coupe-faims-comme-le.md)

Depuis la mise sur le marché du Wegovy en comprimés, les douanes multiplient les contrôles de colis pour freiner les achats illégaux de médicaments coupe-faim sur des sites clandestins. Ces produits figurent parmi les plus saisis.

1 sources, 2 articles · Nationwide

### 3 November 2026 — [Traitement anti-obésité en comprimé : des effets secondaires sur l'économie](https://acturadar.com/en/events/8105-traitement-anti-obesite-en-comprime-des-effets-secondaires-sur-l-economie.md)

Une analyse revient sur l'arrivée d'un traitement anti-obésité disponible en comprimé et sur ses répercussions économiques, au-delà de ses effets secondaires médicaux.

1 sources, 1 articles · Nationwide

### 3 November 2026 — [Les anti-obésité modifient les habitudes alimentaires des patients](https://acturadar.com/en/events/8280-les-anti-obesite-modifient-les-habitudes-alimentaires-des-patients.md)

Une étude du cabinet Bain portant sur des milliers de patients note une baisse de consommation de produits sucrés et de snacks chez les personnes traitées par anti-obésité.

1 sources, 1 articles · Nationwide

---

Cite as: Acturadar, “Arrival of Wegovy in tablet form and tensions around anti-obesity treatments”, https://acturadar.com/en/stories/231-arrival-of-wegovy-in-tablet-form-and-tensions-around-anti-obesity-treatments
Methodology: https://acturadar.com/en/methodology